المؤلفون: E. A. Degtiareva, S. A. Protsenko, E. N. Imyanitov, G. M. Teletaeva, D. Kh. Latipova, A. I. Semenova, A. V. Novik

المصدر: Сибирский онкологический журнал, Vol 21, Iss 5, Pp 162-167 (2022)

مصطلحات موضوعية: metastatic cutaneous melanoma, targeted therapy, immunotherapy, immune checkpoint inhibitors, delayed immune-related adverse events, reactivation of immune-related adverse events, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.siboncoj.ru/jour/article/view/2322; https://doaj.org/toc/1814-4861; https://doaj.org/toc/2312-3168

URL الوصول: https://doaj.org/article/cfda88e2472c45b3aad1f09ca00782ed